• SENSEX 82,184.17
    -542.47 (--0.66%)
  • BANKNIFTY 57,066.05
    -144.40 (--0.25%)
  • Olectra Greentec
    1,590.00 1,786.65(%)
  • Kajaria Ceramics
    1,171.20 745.00(%)
  • Jayaswal Neco
    49.11 55.34(%)
  • Eternal Ltd
    314.40 314.40(%)
  • Force Motors
    20,563.00 20,563.00(%)
  • Kilburn Engg.
    546.50 546.50(%)
  • One 97
    1,128.00 1,128.00(%)
  • Tata Motors
    706.50 1,179.05(%)
  • Datamatics Glob.
    945.70 945.70(%)
  • Bombay Dyeing
    196.50 256.25(%)
  • Indian Energy Ex
    131.50 131.50(%)
  • Kotak Mah. Bank
    2,140.00 1,679.10(%)
  • Swiggy
    429.90 617.00(%)
  • Coforge
    1,670.70 1,120.01(%)
  • Canara Bank
    114.00 119.30(%)
  • Waaree Energies
    3,266.00 3,740.75(%)
  • Tilaknagar Inds.
    505.00 505.00(%)
  • Persistent Sys
    5,084.15 4,163.80(%)
  • Infosys
    1,548.20 1,307.10(%)
  • Ola Electric
    42.36 39.58(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

RPG Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Goenka R P
  • BSE Code : 29175.0
  • ISIN : INE105J01010
2,516.60 22 (0.89%)
  • As on 25 Jul 2025 (EOD)

  • Today’s Low

    2,475.10

  • Today’s High

    2,549.80

  • Open

    2,475.10

  • Perv Close

    2,494.30

  • 52W Low

    1,834.75

  • 52W High

    2,974.95

Key Indicators

  • P/E(TTM)

    35.99

  • Mar.Cap (₹Cr.)

    4,162.21

  • Div & Yield %

    0.95

  • Book Value(₹)

    320.78

  • Debt-Equity Ratio

    0.89

  • AGM Date

    24-Jul-2025

  • EPS

    69.88

  • P/E Ratio

    35.99

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    4,162.21

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.23

  • BV (₹)

    320.80

  • Sales( ₹ in Cr.)

    653.43

  • NP (in Cr.)

    115.58

  • NP Var(%)

    33.0

  • Div%

    300.0

  • CPS (₹)

    82.80

  • EPS (₹)

    69.90

  • Traded Value (₹ in Lakhs)

    4,159.98

  • 52 Week High

    2,974.95

  • 52 Week Low

    1,834.75

  • Price BSE

    2515.0

  • Price NSE

    2,517.00

  • Market Capital( in Cr.)

    4,159.98

  • P/C Ratio

    30.40

  • P/E Ratio

    36.00

  • Price Vs.BV

    69.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 653.43 582.05 512.81 440.16 389.14 375.57
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 653.43 582.05 512.81 440.16 389.14 375.57
Other Income 111.61 7.21 4.80 2.99 0.91 0.73
Stock Adjustments -8.61 -2.70 7.30 25.21 5.01 5.98
Total Income 756.43 586.56 524.91 468.36 395.06 382.28
EXPENDITURE :            
Raw Materials 205.40 181.83 178.17 167.03 136.11 133.74
Power and Fuel Cost 17.66 14.36 13.65 12.69 11.27 11.54
Employee Cost 126.14 132.15 117.06 99.97 94.66 90.97
Other Manufacturing Expenses 28.23 26.07 21.60 22.61 18.48 13.72
Selling and Administration Expenses 95.49 80.47 73.63 67.07 58.40 56.84
Miscellaneous Expenses 27.61 15.33 12.47 8.75 4.30 19.90
Employee Benefit Expenses 126.14 132.15 117.06 99.97 94.66 90.97
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 500.53 450.21 416.58 378.12 323.22 326.71
Operating Profit 255.90 136.35 108.33 90.24 71.84 55.57
Interest 1.59 1.44 1.15 1.41 1.79 2.76
Gross Profit 254.31 134.91 107.18 88.83 70.05 52.81
Depreciation 21.43 17.07 15.50 15.66 16.47 16.36
Profit Before Tax 232.88 117.84 91.68 73.17 53.58 36.45
Current Tax 49.69 32.54 24.35 22.76 17.15 10.10
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.05 -2.36 -0.31 -1.07 -3.57 -2.66
Reported Net Profit 183.24 87.66 67.64 51.48 40.00 29.01
Extraordinary Items 67.66 0.77 -0.57 0.61 -0.01 -3.93
Adjusted Net Profit 115.58 86.89 68.21 50.87 40.01 32.94
Adjustment below Net Profit -1.10 -0.56 0.07 -0.25 -0.12 -0.17
P & L Balance brought forward 318.48 251.23 199.40 160.08 120.20 104.13
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 26.46 19.85 15.88 11.91 0.00 12.77
P & L Balance carried down 474.16 318.48 251.23 199.40 160.08 120.20
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 300.00 200.00 150.00 120.00 90.00 50.00
Dividend Per Share(Rs) 24.00 16.00 12.00 9.60 7.20 4.00
Earnings Per Share-Unit Curr 110.80 53.01 40.90 31.13 24.19 17.54
Earnings Per Share(Adj)-Unit Curr 110.80 53.01 40.90 31.13 24.19 17.54
Book Value 320.80 226.67 186.00 154.66 130.88 106.77
Book Value(Adj)-Unit Curr 320.80 226.67 186.00 154.66 130.88 106.77

Shareholding Pattern

  • Promoter Group

    72.95%

  • Public Share Holding

    27.05%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 533,277 3.22 533,277 10
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 35,662 0.22 35,662 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 8,920,874 53.94 8,920,874 7
Others 0 0.00 0 0
Sub Total 12,065,307 72.95 12,065,307 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,842 0.01 1 6
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 222,975 1.35 222,975 48
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 150 0.00 150 1
Insurance Companies 34,660 0.21 34,660 1
Mutual Funds / UTI 558,409 3.38 558,409 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 477,037 2.88 477,037 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,295,073 7.83 1,293,232 68
2] Non Institution
Bodies Corporate 163,839 0.99 162,755 195
Clearing Members 643 0.00 643 4
Directors of their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 123,967 0.75 123,695 787
Foreign Non Institution Other 2,850 0.02 0 2
Hindu Undivided Families 132,516 0.80 132,502 484
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 33,327 0.20 33,327 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,523,550 15.26 2,378,211 24,242
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 182,468 1.10 182,468 1
Sub Total 3,178,635 19.22 3,028,843 25,744
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,539,015 100.00 16,387,382 25,832

Company Background

RPG Life Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • RPG Life Sciences Ltd
  • BSE Code : 29175.0
  • ISIN : INE105J01010

  • Incorporation Year

    2007

  • Registered Office

    RPG House
    463 Dr Annie Besant Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-24981650

  • FAX

    91-022-24970127

  • Chairman

    H V Goenka

  • Managing Director

    ASHOK NAIR

  • Company Secretary

    Rajesh Shirambekar

  • Auditor

    SRBC & Co LLP

  • Face Value

    8

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

RPG Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
RPG LifeScience. 2,515.25 666.11 653.43 22.70 32.28
Abbott India 34,635.25 6,684.73 6,409.15 52.03 44.95
Astrazeneca Phar 9,021.20 1,756.92 1,716.29 194.84 32.94
P & G Health Ltd 5,829.95 1,166.89 1,151.26 38.53 39.76
Glaxosmi. Pharma 3,159.95 3,866.05 3,723.49 58.25 58.72
Cipla 1,487.25 20,029.57 19,044.85 23.29 21.40
Amrutanjan Healt 700.40 437.58 421.23 39.84 20.84
Fermenta Biotec. 383.00 442.21 430.53 16.67 17.61
Guj. Themis Bio. 363.15 174.19 169.82 81.06 44.82
Bliss GVS Pharma 152.90 703.42 667.20 23.38 9.16
Ambalal Sarabhai 34.63 19.33 4.04 32.06 2.10